No Data
Sage Therapeutics Confirms Receipt of Unsolicited Nonbinding Acquisition Proposal From Biogen
Biogen Proposes to Buy Remaining Stake in Sage in $442 Million Deal
Express News | Sage Therapeutics Shares up 30.2% After the Bell; Biogen Submits Non-Binding Proposal to Buy All Outstanding Shares of Sage Therapeutics' Common Stock Not Owned by Biogen for $7.22/Share in Cash
Express News | Biogen Inc Reports 10.2% Stake in Sage Therapeutics Inc as of Jan 10, 2025
Express News | Biogen Inc Says on January 10, Delivered Letter to Sage Therapeutics' CEO - SEC Filing
Weekly Buzz: CES Came and Brought the Pain? That's Unexpected
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
102124711 : .
Optanie Numa Marc : PLTR is my prediction.
Salini : PLTR
72377867 Jaddy : NDAQ
105251507 : plntr will add..maybe 1 bitcoin company like microstrategy
View more comments...